AU2020903869A0 - Modulating insulin expression and production by targeting cd47 - Google Patents
Modulating insulin expression and production by targeting cd47Info
- Publication number
- AU2020903869A0 AU2020903869A0 AU2020903869A AU2020903869A AU2020903869A0 AU 2020903869 A0 AU2020903869 A0 AU 2020903869A0 AU 2020903869 A AU2020903869 A AU 2020903869A AU 2020903869 A AU2020903869 A AU 2020903869A AU 2020903869 A0 AU2020903869 A0 AU 2020903869A0
- Authority
- AU
- Australia
- Prior art keywords
- targeting
- production
- insulin expression
- modulating insulin
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 230000000051 modifying Effects 0.000 title 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/033,760 US20240091270A1 (en) | 2020-10-26 | 2021-10-26 | Modulating insulin expression and production by targeting cd47 |
| CN202180073321.2A CN116963763A (en) | 2020-10-26 | 2021-10-26 | Modulation of insulin expression and production by targeting CD47 |
| PCT/AU2021/051241 WO2022087658A1 (en) | 2020-10-26 | 2021-10-26 | Modulating insulin expression and production by targeting cd47 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020903869A0 true AU2020903869A0 (en) | 2020-11-12 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3970769A4 (en) | Needleless syringe | |
| EP3625502A4 (en) | Multiview backlight, display, and method employing active emitters | |
| EP2178205B8 (en) | Multi-dimensional volterra series transmitter linearization | |
| EP3938840A4 (en) | Mode-switchable backlight, privacy display, and method employing emitter arrays | |
| EP3788136A4 (en) | Engineered microorganism for the production of cannabinoid biosynthetic pathway products | |
| EP4001487A4 (en) | Fiber structure and production method therefor | |
| EP3917967A4 (en) | Microenvironment sensors to regulate engineered gene expression | |
| EP4040201A4 (en) | Display medium, display product, and display set | |
| EP4061254A4 (en) | Targeting guides | |
| EP3992178A4 (en) | Acrylic ester derivative, and application and production intermediate thereof | |
| EP4064822A4 (en) | Closed-loop, pressurized and sterile, controlled micro-environment cultivation | |
| EP3980563A4 (en) | Ntrk fusion molecules and uses thereof | |
| EP3925652A4 (en) | Safe insulin needle | |
| TWI799840B (en) | Compounds and methods targeting interleukin-34 | |
| AU2020903869A0 (en) | Modulating insulin expression and production by targeting cd47 | |
| EP4026942A4 (en) | Carbon fiber production method and carbon fiber produced using same | |
| EP3912658A4 (en) | Needleless syringe | |
| EP4023272A4 (en) | Needleless syringe having multi-nozzle and manufacturing method therefor | |
| EP4021581A4 (en) | Kmt2a-maml2 fusion molecules and uses thereof | |
| EP4003405A4 (en) | Glucose-responsive insulin conjugates | |
| EP3958914A4 (en) | Engineered cas9 with broadened dna targeting range | |
| EP3911680A4 (en) | Lilrb3-binding molecules and uses therefor | |
| EP3831428A4 (en) | Pre-filled syringe and pre-filled syringe production method | |
| EP3653715A4 (en) | Microorganism expressing active d-proline reductase, and method for producing active d-proline reductase | |
| EP3908612A4 (en) | Constructs targeting labyrinthin or a portion thereof and uses thereof |